Patents Examined by Stephen T Kabushoc
  • Disease risk factors and methods of use
    Patent number: 11021751
    Abstract: Provided herein are genetic variants associated with development of a condition of interest (e.g., Alzheimer's disease). Methods of treatment with an active agent (e.g., with a particular active agent and/or at an earlier age) is also provided, upon detecting a genetic variant described herein. In some embodiments, the genetic variant is a deletion/insertion polymorphism (DIP) of the TOMM40 gene.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: June 1, 2021
    Assignee: Zinfandel Pharmaceuticals, Inc.
    Inventor: Allen D. Roses